Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 693074, 15 pages
http://dx.doi.org/10.1155/2014/693074
Research Article

Diazepam Potentiates the Antidiabetic, Antistress and Anxiolytic Activities of Metformin in Type-2 Diabetes Mellitus with Cooccurring Stress in Experimental Animals

Neurotherapeutics Lab, Department of Pharmaceutics, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India

Received 22 February 2014; Revised 7 May 2014; Accepted 9 May 2014; Published 4 June 2014

Academic Editor: Andrea Mencarelli

Copyright © 2014 Debapriya Garabadu and Sairam Krishnamurthy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Magliano, E. L. M. Barr, P. Z. Zimmet et al., “Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian diabetes, obesity and lifestyle study,” Diabetes Care, vol. 31, no. 2, pp. 267–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Southwick, M. Vythilingam, and D. S. Charney, “The psychobiology of depression and resilience to stress: implications for prevention and treatment,” Annual Review of Clinical Psychology, vol. 1, pp. 255–291, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kumari, J. Head, and M. Marmot, “Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study,” Archives of Internal Medicine, vol. 164, no. 17, pp. 1873–1880, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Heraclides, T. Chandola, D. R. Witte, and E. J. Brunner, “Psychosocial stress at work doubles the risk of type 2 diabetes in middle-aged women: evidence from the Whitehall II study,” Diabetes Care, vol. 32, no. 12, pp. 2230–2235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. P. Cosgrove, L. A. Sargeant, R. Caleyachetty, and S. J. Griffin, “Work-related stress and Type 2 diabetes: systematic review and meta-analysis,” Occupational Medicine, vol. 62, no. 3, pp. 167–173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Garabadu and S. Krishnamurthy, “Temporal effect of repeated stress on type-2 experimental diabetes,” in Diabetes Mellitus and Human Health Care: A Holistic Approach to Diagnosis and Treatment, A. George, R. Augustine, and M. Sebastian, Eds., pp. 357–392, Apple Academic Press, New Jersey, NJ, USA, 2013. View at Google Scholar
  8. M. Stumvoll, B. J. Goldstein, and T. W. van Haeften, “Type 2 diabetes: principles of pathogenesis and therapy,” The Lancet, vol. 365, no. 9467, pp. 1333–1346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. W.-Q. Zhao and M. Townsend, “Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1792, no. 5, pp. 482–496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Y. Donath and S. E. Shoelson, “Type 2 diabetes as an inflammatory disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 98–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. G. S. Hotamisligil, R. S. Johnson, R. J. Distel, R. Ellis, V. E. Papaioannou, and B. M. Spiegelman, “Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein,” Science, vol. 274, no. 5291, pp. 1377–1379, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Pessin and A. R. Saltiel, “Signaling pathways in insulin action: molecular targets of insulin resistance,” Journal of Clinical Investigation, vol. 106, no. 2, pp. 165–169, 2000. View at Google Scholar · View at Scopus
  13. V. Aguirre, E. D. Werner, J. Giraud, Y. H. Lee, S. E. Shoelson, and M. F. White, “Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action,” Journal of Biological Chemistry, vol. 277, no. 2, pp. 1531–1537, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Li, K.-I. Okamoto, Y. Hayashi, and M. Sheng, “The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses,” Cell, vol. 119, no. 6, pp. 873–887, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Chen, G. C. Owens, K. L. Crossin, and D. B. Edelman, “Serotonin stimulates mitochondrial transport in hippocampal neurons,” Molecular and Cellular Neuroscience, vol. 36, no. 4, pp. 472–483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Chen, G. C. Owens, and D. B. Edelman, “Dopamine inhibits mitochondrial motility in hippocampal neurons,” PLoS ONE, vol. 3, no. 7, Article ID e2804, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Cardoso, M. S. Santos, A. Moreno, and P. I. Moreira, “UCP2 and ANT differently modulate proton-leak in brain mitochondria of long-term hyperglycemic and recurrent hypoglycemic rats,” Journal of Bioenergetics and Biomembranes, vol. 45, no. 4, pp. 397–407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. T. V. Fiorentino, A. Prioletta, P. Zuo, and F. Folli, “Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases,” Current Pharmaceutical Design, vol. 19, no. 32, pp. 5695–5703, 2013. View at Publisher · View at Google Scholar
  20. V. V. Davydov and I. V. Volkova, “Effect of stress on the content of free radical oxidation products in subcellular brain fractions in rats of pubertal age,” Ukrain'skyi Biokhimichnyi Zhurnal, vol. 81, no. 2, pp. 102–106, 2009. View at Google Scholar · View at Scopus
  21. K. A. Rasbach and R. G. Schnellmann, “Signaling of mitochondrial biogenesis following oxidant injury,” Journal of Biological Chemistry, vol. 282, no. 4, pp. 2355–2362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. O. Goodarzi and M. Bryer-Ash, “Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents,” Diabetes, Obesity and Metabolism, vol. 7, no. 6, pp. 654–665, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Nathan, J. B. Buse, M. B. Davidson et al., “Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: aonsensus statement from the American diabetes association and the European association for the study of diabetes,” Diabetologia, vol. 52, no. 1, pp. 17–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Foretz, S. Hébrard, J. Leclerc et al., “Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state,” Journal of Clinical Investigation, vol. 120, no. 7, pp. 2355–2369, 2010. View at Publisher · View at Google Scholar
  25. M.-Y. El-Mir, V. Nogueira, E. Fontaine, N. Avéret, M. Rigoulet, and X. Leverve, “Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I,” Journal of Biological Chemistry, vol. 275, no. 1, pp. 223–228, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Guigas, D. Detaille, C. Chauvin et al., “Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study,” Biochemical Journal, vol. 382, no. 3, pp. 877–884, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Okada, K. Ichiki, S. Tanokuchi, K. Ishii, H. Hamada, and Z. Ota, “Effect of an anxiolytic on lipid profile in non-insulin dependent diabetes mellitus,” Journal of International Medical Research, vol. 22, no. 6, pp. 338–342, 1994. View at Google Scholar · View at Scopus
  28. S. Okada, K. Ichiki, S. Tanokuchi, K. Ishii, H. Hamada, and Z. Ota, “How blood pressure in patients with non-insulin-dependent diabetes mellitus is influenced by stress,” Journal of International Medical Research, vol. 23, no. 5, pp. 377–380, 1995. View at Google Scholar · View at Scopus
  29. F. A. A. Al-Ahmed, E. S. M. El-Denshary, M. Zaki, H. A. El-Sawaf, and A. R. Abu-Jayyab, “Interaction between diazepam and oral antidiabetic agents on serum glucose, insulin and chromium levels in rats,” Bioscience Reports, vol. 9, no. 3, pp. 347–350, 1989. View at Google Scholar · View at Scopus
  30. A. Sarnowska, M. Beresewicz, B. Zabłocka, and K. Domańska-Janik, “Diazepam neuroprotection in excitotoxic and oxidative stress involves a mitochondrial mechanism additional to the GABAAR and hypothermic effects,” Neurochemistry International, vol. 55, no. 1–3, pp. 164–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Chelli, A. Lena, R. Vanacore et al., “Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells,” Biochemical Pharmacology, vol. 68, no. 1, pp. 125–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Marselli, L. Trincavelli, C. Santangelo et al., “The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets,” European Journal of Endocrinology, vol. 151, no. 2, pp. 207–214, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Masiello, C. Broca, R. Gross et al., “Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide,” Diabetes, vol. 47, no. 2, pp. 224–229, 1998. View at Google Scholar · View at Scopus
  34. R. M. Sullivan and H. Szechtman, “Asymmetrical influence of mesocortical dopamine depletion on stress ulcer development and subcortical dopamine systems in rats: implications for psychopathology,” Neuroscience, vol. 65, no. 3, pp. 757–766, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Yanardag, O. Ozsoy-Sacan, S. Bolkent, H. Orak, and O. Karabulut-Bulan, “Protective effects of metformin treatment on the liver injury of streptozotocin-diabetic rats,” Human and Experimental Toxicology, vol. 24, no. 3, pp. 129–135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Beattie, “Effect of drugs on rats exposed to cold-restraint stress,” Journal of Pharmacy and Pharmacology, vol. 29, no. 12, pp. 748–751, 1977. View at Google Scholar · View at Scopus
  37. D. Kumar, Z. A. Bhat, V. Kumar, W. Y. Raja, and M. Y. Shah, “Anti-anxiety activity of Stachys tibetica Vatke,” Chinese Journal of Natural Medicines, vol. 11, no. 3, pp. 240–244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Palkovits and M. J. Brownstein, Maps and Guide to Microdissection of the Rat Brain, Elsevier, New York, NY, USA, 1988.
  39. J. M. Rijkelijkhuizen, T. Doesburg, C. J. Girman et al., “Hepatic fat is not associated with β-cell function or postprandial free fatty acid response,” Metabolism: Clinical and Experimental, vol. 58, no. 2, pp. 196–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. Wang, C. Jiang, S. Fang et al., “Antihyperglycemic, antihyperlipidemic and antioxidant effects of ethanol and aqueous extracts of Cyclocarya paliurus leaves in type 2 diabetic rats,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 1119–1127, 2013. View at Publisher · View at Google Scholar
  41. A. Duseja, K. K. Thumburu, A. Das et al., “Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease,” Indian Journal of Gastroenterology, vol. 26, no. 4, pp. 170–173, 2007. View at Google Scholar · View at Scopus
  42. R. Muniyappa, S. Lee, H. Chen, and M. J. Quon, “Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 294, no. 1, pp. E15–E26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. P. M. Toleikis and D. V. Godin, “Alteration of antioxidant status in diabetic rats by chronic exposure to psychological stressors,” Pharmacology Biochemistry and Behavior, vol. 52, no. 2, pp. 355–366, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. C. J. H. Woodward and P. W. Emery, “Determination of plasma corticosterone using high-performance liquid chromatography,” Journal of Chromatography, vol. 419, pp. 280–284, 1987. View at Google Scholar · View at Scopus
  45. D. Garabadu, A. Shah, A. Ahmad et al., “Eugenol as an anti-stress agent: modulation of hypothalamic-pituitary- adrenal axis and brain monoaminergic systems in a rat model of stress,” Stress, vol. 14, no. 2, pp. 145–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Sairam, C. V. Rao, M. D. Babu, K. V. Kumar, V. K. Agrawal, and R. K. Goel, “Antiulcerogenic effect of methanolic extract of Emblica officinalis: an experimental study,” Journal of Ethnopharmacology, vol. 82, no. 1, pp. 1–9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Pellow, P. Chopin, S. E. File, and M. Briley, “Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat,” Journal of Neuroscience Methods, vol. 14, no. 3, pp. 149–167, 1985. View at Google Scholar · View at Scopus
  48. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  49. P. L. Pedersen, J. W. Greenawalt, B. Reynafarje et al., “Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues,” Methods in Cell Biology, vol. 20, pp. 411–481, 1978. View at Google Scholar · View at Scopus
  50. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  51. S. L. Old and M. A. Johnson, “Methods of microphotometric assay of succinate dehydrogenase and cytochrome C oxidase activities for use on human skeletal muscle,” Histochemical Journal, vol. 21, no. 9-10, pp. 545–555, 1989. View at Google Scholar · View at Scopus
  52. S.-G. Huang, “Development of a high throughput screening assay for mitochondrial membrane potential in living cells,” Journal of Biomolecular Screening, vol. 7, no. 4, pp. 383–389, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  54. F. W. Sunderman Jr., A. Marzouk, S. M. Hopfer, O. Zaharia, and M. C. Reid, “Increased lipid peroxidation in tissues of nickel chloride-treated rats,” Annals of Clinical and Laboratory Science, vol. 15, no. 3, pp. 229–236, 1985. View at Google Scholar · View at Scopus
  55. P. Kakkar, B. Das, and P. N. Viswanathan, “A modified spectrophotometric assay of superoxide dismutase,” Indian Journal of Biochemistry and Biophysics, vol. 21, no. 2, pp. 130–132, 1984. View at Google Scholar · View at Scopus
  56. R. F. Beers Jr. and I. W. Sizer, “A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase,” The Journal of Biological Chemistry, vol. 195, no. 1, pp. 133–140, 1952. View at Google Scholar · View at Scopus
  57. T. A. Buchanan, A. H. Xiang, R. K. Peters et al., “Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women,” Diabetes, vol. 51, no. 9, pp. 2796–2803, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. L. H. Gao, Q. Liu, S. N. Liu et al., “A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 675–685, 2014. View at Publisher · View at Google Scholar
  59. K. Okada, T. Hirano, J. Ran, and M. Adachi, “Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats,” Hypertension Research, vol. 27, no. 4, pp. 293–299, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. E. P. Davila, H. Florez, M. J. Trepka et al., “Long work hours is associated with suboptimal glycemic control among US workers with diabetes,” The American Journal of Industrial Medicine, vol. 54, no. 5, pp. 375–383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Faulenbach, H. Uthoff, K. Schwegler, G. A. Spinas, C. Schmid, and P. Wiesli, “Effect of psychological stress on glucose control in patients with type 2 diabetes,” Diabetic Medicine, vol. 29, no. 1, pp. 128–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Karamanos, A. Thanopoulou, V. Drossinos, E. Charalampidou, S. Sourmeli, and A. Archimandritis, “Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA),” Current Medical Research and Opinion, vol. 27, no. 2, pp. 303–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Chen, H. Xiong, J. Wang, X. Ding, G. Shu, and Z. Mei, “Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats,” Journal of Ethnopharmacology, vol. 149, no. 3, pp. 729–736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. T.-Y. Wang, X.-Q. Chen, J.-Z. Du, N.-Y. Xu, C.-B. Wei, and W. W. Vale, “Corticotropin-releasing factor receptor type 1 and 2 mRNA expression in the rat anterior pituitary is modulated by intermittent hypoxia, cold and restraint,” Neuroscience, vol. 128, no. 1, pp. 111–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Kumar, S. Aravamudhan, M. Gordic, S. Bhansali, and S. S. Mohapatra, “Ultrasensitive detection of cortisol with enzyme fragment complementation technology using functionalized nanowire,” Biosensors and Bioelectronics, vol. 22, no. 9-10, pp. 2138–2144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. C. de Oliveira, A. B. de Mattos, C. Biz, L. M. Oyama, E. B. Ribeiro, and C. M. O. Do Nascimento, “High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations,” Lipids in Health and Disease, vol. 10, article 11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Krishnamurthy, D. Garabadu, and N. R. Reddy, “Asparagus racemosus modulates the hypothalamic-pituitary-adrenal axis and brain monoaminergic systems in rats,” Nutritional Neuroscience, vol. 16, no. 6, pp. 255–261, 2013. View at Publisher · View at Google Scholar
  68. M. E. Cleasby, D. E. W. Livingstone, M. J. Nyirenda, J. R. Seckl, and B. R. Walker, “Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood?” European Journal of Endocrinology, vol. 148, no. 1, pp. 129–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Carrizo, V. Fernández, I. Sandia et al., “Extended release metfomin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study,” Schizophrenia Research, vol. 113, no. 1, pp. 19–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. C. López-Rubalcava, N. Paez-Martinez, and J. Oikawa, “Blockade of corticosteroid receptors induces anxiolytic-like effects in streptozotocin-induced diabetic mice, and synergizes with diazepam,” Behavioural Pharmacology, vol. 24, no. 4, pp. 320–327, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Lloyd, J. Smith, and K. Weinger, “Stress and diabetes: a review of the links,” Diabetes Spectrum, vol. 18, no. 2, pp. 121–127, 2005. View at Publisher · View at Google Scholar
  72. L. Fisher, J. T. Mullan, M. M. Skaff, R. E. Glasgow, P. Arean, and D. Hessler, “Predicting diabetes distress in patients with Type 2 diabetes: a longitudinal study,” Diabetic Medicine, vol. 26, no. 6, pp. 622–627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. R. J. Anderson, M. de Groot, A. B. Grigsby et al., “Anxiety and poor glycemic control: a meta-analytic review of the literature,” International Journal of Psychiatry in Medicine, vol. 32, no. 3, pp. 235–247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. L. A. Hilakivi-Clarke, K. M. Wozniak, M. J. Durcan, and M. Linnoila, “Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and agression,” Physiology and Behavior, vol. 48, no. 3, pp. 429–433, 1990. View at Publisher · View at Google Scholar · View at Scopus
  75. A. R. Saltiel and C. R. Kahn, “Insulin signalling and the regulation of glucose and lipid metabolism,” Nature, vol. 414, no. 6865, pp. 799–806, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. A. R. Saltiel and J. E. Pessin, “Insulin signaling pathways in time and space,” Trends in Cell Biology, vol. 12, no. 2, pp. 65–71, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. J. F. Vecina, A. G. Oliveira, T. G. Araujo et al., “Chlorella modulates insulin signaling pathway and prevents high-fat diet-induced insulin resistance in mice,” Life Sciences, vol. 95, no. 1, pp. 45–52, 2014. View at Publisher · View at Google Scholar
  78. M.-Y. El-Mir, D. Detaille, G. R-Villanueva et al., “Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons,” Journal of Molecular Neuroscience, vol. 34, no. 1, pp. 77–87, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Pintana, N. Apaijai, W. Pratchayasakul, N. Chattipakorn, and S. C. Chattipakorn, “Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats,” Life Sciences, vol. 91, no. 11-12, pp. 409–414, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Fukui, K. Onodera, T. Shinkai, S. Suzuki, and S. Urano, “Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems,” Annals of the New York Academy of Sciences, vol. 928, pp. 168–175, 2001. View at Google Scholar · View at Scopus
  81. P. Bhutada, Y. Mundhada, K. Bansod et al., “Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes,” Behavioural Brain Research, vol. 220, no. 1, pp. 30–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. K. O. Menabde, G. M. Burdzhanadze, M. V. Chachua, Z. T. Kuchukashvyly, and N. I. Koshorydze, “Tissue specificity of lipid peroxidation under emotional stress in rats,” Ukrainskiǐ Biokhimicheskiǐ Zhurnal, vol. 83, no. 3, pp. 85–90, 2011. View at Google Scholar · View at Scopus